Aberrations in Lipid Expression and Metabolism in Psoriasis

Area of Science:

• Dermatology
• Metabolic Disorders
• Cardiovascular Health

Background:

• Psoriasis (PSO) affects 1%-3% of the population, posing significant medical, social, and economic burdens.
• PSO is frequently linked to cardiometabolic comorbidities, including obesity, dyslipidemia, atherosclerosis, and nonalcoholic fatty liver disease.
• Abnormal lipid expression and metabolism are increasingly recognized in psoriatic patients.

Purpose of the Study:

• To review the various lipid aberrations observed in the skin, blood, and adipose tissue of patients with psoriasis.
• To explore the multifactorial impact of these lipid abnormalities on the pathogenesis of psoriasis.

Main Methods:

• Literature review of studies investigating lipid metabolism in psoriasis.
• Analysis of research on comorbidities associated with psoriasis.
• Synthesis of findings on lipid expression and metabolic disorders in psoriatic skin, blood, and adipose tissue.

Main Results:

• Psoriatic patients exhibit frequent dyslipidemia, obesity, and nonalcoholic fatty liver disease.
• Significant alterations in lipid profiles are evident in the skin, blood, and adipose tissue of individuals with psoriasis.
• These lipid disorders are implicated as key contributors to the multifactorial pathogenesis of psoriasis.

Conclusions:

• Lipid metabolism aberrations are a critical component in the pathogenesis of psoriasis.
• Understanding these lipid alterations is essential for managing psoriasis and its associated cardiometabolic comorbidities.
• Further research into lipid pathways may reveal novel therapeutic targets for psoriasis treatment.